Reuters accidentally breaks embargo on NEJM Eliquis study
The original story ran sometime this morning. This ran at the end of the refiled Reuters story, which posted at 9:58 Eastern:
(Reuters inadvertently issued the story headlined “New clot preventer works as well as warfarin with less bleeding.” The story was under embargo for 1000 GMT (6:00 a.m. EDT), July 1)
This is Reuters’ second embargo break in the month of June. As I wrote on June 12 in a post about the earlier one:
As has been the case with another embargo break involving my colleagues, I won’t comment beyond what’s publicly available, given the conflict of interest. (The team I lead at Reuters Health broke one in November, I should point out.) Thanks for understanding.